These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 18544939)
1. Syndecan-1 expression in gallbladder cancer and its prognostic significance. Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS Eur Surg Res; 2008; 41(2):245-50. PubMed ID: 18544939 [TBL] [Abstract][Full Text] [Related]
2. Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer. Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS J Hepatobiliary Pancreat Surg; 2009; 16(3):315-21. PubMed ID: 19259612 [TBL] [Abstract][Full Text] [Related]
3. Correlation between MMP1-PAR1 axis and clinical outcome of primary gallbladder carcinoma. Du X; Wang S; Lu J; Cao Y; Song N; Yang T; Dong R; Zang L; Yang Y; Wu T; Li J Jpn J Clin Oncol; 2011 Sep; 41(9):1086-93. PubMed ID: 21835828 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy. Shariat SF; Svatek RS; Kabbani W; Walz J; Lotan Y; Karakiewicz PI; Roehrborn CG BJU Int; 2008 Jan; 101(2):232-7. PubMed ID: 17868422 [TBL] [Abstract][Full Text] [Related]
5. Heparanase expression in gallbladder carcinoma and its correlation to prognosis. Wu W; Pan C; Yu H; Gong H; Wang Y J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042 [TBL] [Abstract][Full Text] [Related]
6. A prognostic value of syndecan-1 in gastric cancer. Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C Anticancer Res; 2000; 20(6D):4905-7. PubMed ID: 11326638 [TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer. Kim WB; Han HJ; Lee HJ; Park SS; Song TJ; Kim HK; Suh SO; Kim YC; Choi SY Ann Surg Oncol; 2009 Jan; 16(1):23-34. PubMed ID: 18979138 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder. Liu DC; Yang ZL Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma. Zhou L; He XD; Chen J; Cui QC; Qu Q; Rui JA; Zhao YP Eur J Cancer; 2007 Mar; 43(4):809-15. PubMed ID: 17276673 [TBL] [Abstract][Full Text] [Related]
10. Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract. Sung JY; Kim GY; Lim SJ; Park YK; Kim YW Pathol Res Pract; 2010 Jan; 206(1):24-9. PubMed ID: 19819644 [TBL] [Abstract][Full Text] [Related]
11. Expression of CDC6 and GDF-9 and their clinicopathological significances in benign and malignant lesions of the gallbladder. Shu GS; Yang LP; Yang ZL; Jiang S Cancer Biomark; 2012; 11(2-3):107-14. PubMed ID: 23011157 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity. Jackson LL; Wade Z; Hessler RB; Abdelsayed R; Rogers JB; Gourin CG Laryngoscope; 2007 May; 117(5):868-71. PubMed ID: 17473685 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of sialyl Lex expression in human gallbladder carcinoma. Kashiwagi H; Kijima H; Dowaki S; Ohtani Y; Tobita K; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Imaizumi T; Makuuchi H Oncol Rep; 2004 Jun; 11(6):1139-43. PubMed ID: 15138547 [TBL] [Abstract][Full Text] [Related]
15. Expression of standard CD44 in human colorectal carcinoma: association with prognosis. Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367 [TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of syndecan-1 and syndecan-2 expression in gallbladder squamous cell/adenosquamous carcinoma and adenocarcinoma]. Tan XG; Yang ZL; Miao XY; Liu ZR; Li DQ; Zou Q; Li JH; Liang LF Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):28-34. PubMed ID: 29365414 [No Abstract] [Full Text] [Related]
17. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer. Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224 [TBL] [Abstract][Full Text] [Related]
18. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma. Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327 [TBL] [Abstract][Full Text] [Related]
19. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer. Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422 [TBL] [Abstract][Full Text] [Related]
20. L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma. Choi SY; Jo YS; Huang SM; Liang ZL; Min JK; Hong HJ; Kim JM Hum Pathol; 2011 Oct; 42(10):1476-83. PubMed ID: 21496863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]